Bristol Myers Squibb (BMY) Income towards Parent Company (2016 - 2025)
Historic Income towards Parent Company for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to $2.2 billion.
- Bristol Myers Squibb's Income towards Parent Company rose 8971.48% to $2.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.0 billion, marking a year-over-year increase of 42255.83%. This contributed to the annual value of -$8.9 billion for FY2024, which is 21110.7% down from last year.
- As of Q3 2025, Bristol Myers Squibb's Income towards Parent Company stood at $2.2 billion, which was up 8971.48% from $1.3 billion recorded in Q2 2025.
- In the past 5 years, Bristol Myers Squibb's Income towards Parent Company ranged from a high of $2.5 billion in Q1 2025 and a low of -$11.9 billion during Q1 2024
- Moreover, its 5-year median value for Income towards Parent Company was $1.6 billion (2024), whereas its average is $953.6 million.
- In the last 5 years, Bristol Myers Squibb's Income towards Parent Company skyrocketed by 78150.68% in 2021 and then plummeted by 62527.57% in 2024.
- Over the past 5 years, Bristol Myers Squibb's Income towards Parent Company (Quarter) stood at $2.4 billion in 2021, then decreased by 14.63% to $2.0 billion in 2022, then dropped by 12.99% to $1.8 billion in 2023, then plummeted by 95.69% to $76.0 million in 2024, then skyrocketed by 2788.16% to $2.2 billion in 2025.
- Its last three reported values are $2.2 billion in Q3 2025, $1.3 billion for Q2 2025, and $2.5 billion during Q1 2025.